Use of Vancomycin-Containing Lock or Flush Solutions for Prevention of Bloodstream Infection Associated with Central Venous Access Devices: A Meta-Analysis of Prospective, Randomized Trials | Zendy

Nasia Safdar | Zendy; D. G. Maki | Zendy

Open Access

Use of Vancomycin-Containing Lock or Flush Solutions for Prevention of Bloodstream Infection Associated with Central Venous Access Devices: A Meta-Analysis of Prospective, Randomized Trials

Author(s) -

Nasia Safdar,

D. G. Maki

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/505976

Subject(s) - medicine , vancomycin , randomized controlled trial , heparin , bloodstream infection , meta analysis , confidence interval , central venous catheter , intensive care medicine , population , relative risk , prospective cohort study , surgery , intensive care , catheter , environmental health , biology , bacteria , genetics , staphylococcus aureus

Prolonged exposure to central venous access devices carries significant risk of device-associated bloodstream infection (BSI), which is associated with morbidity, added health care costs, and attributable mortality. We aimed to determine the efficacy of vancomycin-heparin lock or flush solution in preventing BSI in patients being treated with long-term central venous intravascular devices (IVDs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research